IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread

Cell Host and Microbe

Volumn 16, Issue 6, 2014, Pages 736-747

  Compton, Alex A ^a,b   Bruel, Timothée ^a,b   Porrot, Françoise ^a,b   Mallet, Adeline ^a   Sachse, Martin ^a   Euvrard, Marine ^a,c   Liang, Chen ^d   Casartelli, Nicoletta ^a,b   Schwartz, Olivier ^a,b,e  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d MCGILL UNIVERSITY   (Canada)

^e Vaccine Research Institute   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; INTERFERON INDUCED TRANSMEMBRANE PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; DIFFERENTIATION ANTIGEN; IFITM2 PROTEIN, HUMAN; IFITM3 PROTEIN, HUMAN; LEU-13 ANTIGEN; RNA BINDING PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL FUSION; CELL SPREADING; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; LIFE CYCLE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TARGET CELL; VIRION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS STRAIN; VIRUS TRANSMISSION; CELL LINE; CELL MEMBRANE; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS ENTRY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL MEMBRANE; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE PROTEINS; RNA-BINDING PROTEINS; VIRION; VIRUS INTERNALIZATION;

EID: 84920602734     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2014.11.001     Document Type: Article

References (51)

1. M.A. Accola, A. Ohagen, and H.G. Göttlinger Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag) J. Virol. 74 2000 6198 6202
2. S. Amini-Bavil-Olyaee, Y.J. Choi, J.H. Lee, M. Shi, I.C. Huang, M. Farzan, and J.U. Jung The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry Cell Host Microbe 13 2013 452 464
3. C. Arenaccio, C. Chiozzini, S. Columba-Cabezas, F. Manfredi, E. Affabris, A. Baur, and M. Federico Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism J. Virol. 88 2014 11529 11539
4. C.C. Bailey, I.C. Huang, C. Kam, and M. Farzan Ifitm3 limits the severity of acute influenza in mice PLoS Pathog. 8 2012 e1002909
5. A.L. Brass, I.C. Huang, Y. Benita, S.P. John, M.N. Krishnan, E.M. Feeley, B.J. Ryan, J.L. Weyer, L. van der Weyden, and E. Fikrig The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus Cell 139 2009 1243 1254
6. R. Cantin, J. Diou, D. Bélanger, A.M. Tremblay, and C. Gilbert Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants J. Immunol. Methods 338 2008 21 30
7. N. Casartelli, M. Sourisseau, J. Feldmann, F. Guivel-Benhassine, A. Mallet, A.G. Marcelin, J. Guatelli, and O. Schwartz Tetherin restricts productive HIV-1 cell-to-cell transmission PLoS Pathog. 6 2010 e1000955
8. M. Cavrois, C. De Noronha, and W.C. Greene A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes Nat. Biotechnol. 20 2002 1151 1154
9. N.M. Chesarino, T.M. McMichael, J.C. Hach, and J.S. Yount Phosphorylation of the antiviral protein interferon-inducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitination J. Biol. Chem. 289 2014 11986 11992
10. N. Chutiwitoonchai, M. Hiyoshi, Y. Hiyoshi-Yoshidomi, M. Hashimoto, K. Tokunaga, and S. Suzu Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins Microbes Infect. 15 2013 280 290
11. B.M. Dale, R.A. Alvarez, and B.K. Chen Mechanisms of enhanced HIV spread through T-cell virological synapses Immunol. Rev. 251 2013 113 124
12. M. Deneka, A. Pelchen-Matthews, R. Byland, E. Ruiz-Mateos, and M. Marsh In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53 J. Cell Biol. 177 2007 329 341
13. T.M. Desai, M. Marin, C.R. Chin, G. Savidis, A.L. Brass, and G.B. Melikyan IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion PLoS Pathog. 10 2014 e1004048
14. M.S. Diamond, and M. Farzan The broad-spectrum antiviral functions of IFIT and IFITM proteins Nat. Rev. Immunol. 13 2013 46 57
15. S. Ding, Q. Pan, S.-L. Liu, and C. Liang HIV-1 mutates to evade IFITM1 restriction Virology 454-455 2014 11 24
16. N.K. Duggal, and M. Emerman Evolutionary conflicts between viruses and restriction factors shape immunity Nat. Rev. Immunol. 12 2012 687 695
17. A.R. Everitt, S. Clare, T. Pertel, S.P. John, R.S. Wash, S.E. Smith, C.R. Chin, E.M. Feeley, J.S. Sims, D.J. Adams GenISIS Investigators MOSAIC Investigators IFITM3 restricts the morbidity and mortality associated with influenza Nature 484 2012 519 523
18. E.M. Feeley, J.S. Sims, S.P. John, C.R. Chin, T. Pertel, L.-M. Chen, G.D. Gaiha, B.J. Ryan, R.O. Donis, S.J. Elledge, and A.L. Brass IFITM3 inhibits influenza A virus infection by preventing cytosolic entry PLoS Pathog. 7 2011 e1002337
19. O. Haller Dynamins are forever: MxB inhibits HIV-1 Cell Host Microbe 14 2013 371 373
20. D. Hickford, S. Frankenberg, G. Shaw, and M.B. Renfree Evolution of vertebrate interferon inducible transmembrane proteins BMC Genomics 13 2012 155
21. I.C. Huang, C.C. Bailey, J.L. Weyer, S.R. Radoshitzky, M.M. Becker, J.J. Chiang, A.L. Brass, A.A. Ahmed, X. Chi, and L. Dong Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus PLoS Pathog. 7 2011 e1001258
22. R. Jia, Q. Pan, S. Ding, L. Rong, S.L. Liu, Y. Geng, W. Qiao, and C. Liang The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization J. Virol. 86 2012 13697 13707
23. R. Jia, F. Xu, J. Qian, Y. Yao, C. Miao, Y.-M. Zheng, S.-L. Liu, F. Guo, Y. Geng, W. Qiao, and C. Liang Identification of an endocytic signal essential for the antiviral action of IFITM3 Cell. Microbiol. 16 2014 1080 1093
24. S.P. John, C.R. Chin, J.M. Perreira, E.M. Feeley, A.M. Aker, G. Savidis, S.E. Smith, A.E.H. Elia, A.R. Everitt, and M. Vora The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication J. Virol. 87 2013 7837 7852
25. M. Jouve, N. Sol-Foulon, S. Watson, O. Schwartz, and P. Benaroch HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages Cell Host Microbe 2 2007 85 95
26. N. Laguette, and M. Benkirane How SAMHD1 changes our view of viral restriction Trends Immunol. 33 2012 26 33
27. S. Le Gall, M.C. Prevost, J.M. Heard, and O. Schwartz Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity Virology 229 1997 295 301
28. A. Lepelley, S. Louis, M. Sourisseau, H.K. Law, J. Pothlichet, C. Schilte, L. Chaperot, J. Plumas, R.E. Randall, and M. Si-Tahar Innate sensing of HIV-infected cells PLoS Pathog. 7 2011 e1001284
29. K. Li, R.M. Markosyan, Y.-M. Zheng, O. Golfetto, B. Bungart, M. Li, S. Ding, Y. He, C. Liang, and J.C. Lee IFITM proteins restrict viral membrane hemifusion PLoS Pathog. 9 2013 e1003124
30. T.-Y. Lin, C.R. Chin, A.R. Everitt, S. Clare, J.M. Perreira, G. Savidis, A.M. Aker, S.P. John, D. Sarlah, and E.M. Carreira Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction Cell Rep. 5 2013 895 908
31. J. Lu, Q. Pan, L. Rong, W. He, S.L. Liu, and C. Liang The IFITM proteins inhibit HIV-1 infection J. Virol. 85 2011 2126 2137
32. M. Malbec, F. Porrot, R. Rua, J. Horwitz, F. Klein, A. Halper-Stromberg, J.F. Scheid, C. Eden, H. Mouquet, M.C. Nussenzweig, and O. Schwartz Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission J. Exp. Med. 210 2013 2813 2821
33. M.H. Malim, and P.D. Bieniasz HIV restriction factors and mechanisms of evasion Cold Spring Harb Perspect Med 2 2012 a006940
34. R. Mudhasani, J.P. Tran, C. Retterer, S.R. Radoshitzky, K.P. Kota, L.A. Altamura, J.M. Smith, B.Z. Packard, J.H. Kuhn, and J. Costantino IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus J. Virol. 87 2013 8451 8464
35. T.T. Murooka, M. Deruaz, F. Marangoni, V.D. Vrbanac, E. Seung, U.H. von Andrian, A.M. Tager, A.D. Luster, and T.R. Mempel HIV-infected T cells are migratory vehicles for viral dissemination Nature 490 2012 283 287
36. J.M. Perreira, C.R. Chin, E.M. Feeley, and A.L. Brass IFITMs restrict the replication of multiple pathogenic viruses J. Mol. Biol. 425 2013 4937 4955
37. R.A.S. Raposo, M. Abdel-Mohsen, M. Bilska, D.C. Montefiori, D.F. Nixon, and S.K. Pillai Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells J. Virol. 87 2013 11924 11929
38. F. Roesch, O. Meziane, A. Kula, S. Nisole, F. Porrot, I. Anderson, F. Mammano, A. Fassati, A. Marcello, M. Benkirane, and O. Schwartz Hyperthermia stimulates HIV-1 replication PLoS Pathog. 8 2012 e1002792
39. D. Rudnicka, J. Feldmann, F. Porrot, S. Wietgrefe, S. Guadagnini, M.C. Prévost, J. Estaquier, A.T. Haase, N. Sol-Foulon, and O. Schwartz Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses J. Virol. 83 2009 6234 6246
40. Q.J. Sattentau The direct passage of animal viruses between cells Curr Opin Virol 1 2011 396 402
41. M.L. Shaw, K.L. Stone, C.M. Colangelo, E.E. Gulcicek, and P. Palese Cellular proteins in influenza virus particles PLoS Pathog. 4 2008 e1000085
42. F. Siegrist, M. Ebeling, and U. Certa The small interferon-induced transmembrane genes and proteins J. Interferon Cytokine Res. 31 2011 183 197
43. S. Smith, S. Weston, P. Kellam, and M. Marsh IFITM proteins-cellular inhibitors of viral entry Curr Opin Virol 4 2014 71 77
44. M. Sourisseau, N. Sol-Foulon, F. Porrot, F. Blanchet, and O. Schwartz Inefficient human immunodeficiency virus replication in mobile lymphocytes J. Virol. 81 2007 1000 1012
45. W.I. Sundquist, and H.G. Kräusslich HIV-1 assembly, budding, and maturation Cold Spring Harb Perspect Med 2 2012 a006924
46. Y. Tang, I.C. Leao, E.M. Coleman, R.S. Broughton, and J.E.K. Hildreth Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartments J. Virol. 83 2009 7982 7995
47. S. Wang, X. Chi, H. Wei, Y. Chen, Z. Chen, S. Huang, and J.L. Chen Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression J. Virol. 88 2014 8375 8385
48. S. Welsch, O.T. Keppler, A. Habermann, I. Allespach, J. Krijnse-Locker, and H.G. Kräusslich HIV-1 buds predominantly at the plasma membrane of primary human macrophages PLoS Pathog. 3 2007 e36
49. S. Weston, S. Czieso, I.J. White, S.E. Smith, P. Kellam, and M. Marsh A membrane topology model for human interferon inducible transmembrane protein 1 PLoS ONE 9 2014 e104341
50. S. Wildum, M. Schindler, J. Münch, and F. Kirchhoff Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection J. Virol. 80 2006 8047 8059
51. J.S. Yount, B. Moltedo, Y.-Y. Yang, G. Charron, T.M. Moran, C.B. López, and H.C. Hang Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3 Nat. Chem. Biol. 6 2010 610 614